Published in Health Risk Factor Week, December 5th, 2006
This trend article about Keio University, Japan, is an immediate alert from NewsRx to identify developing directions of research.
According to recent research from Japan, "Recent clinical trials have shown that IFN is effective for chemoprevention against HCC. However, it remains controversial as to whether IFN exerts direct cytotoxicity against HCC."
"COX-2 also plays a role in hepatocarcinogenesis and may...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.